Risultati per: Gestione del carcinoma polmonare (cancro al polmone) non a piccole cellule

Currently, patients with hepatocellular carcinoma (HCC) in the United States are assigned a uniform score relative to the median MELD at transplant (MMaT-3) after a minimum 6-month waiting period. Here, we develop a risk stratification model for patients with HCC, using the available and objective variables at time of listing.

New England Journal of Medicine, Volume 391, Issue 21, Page 2061-2063, November 28, 2024.

Focus su tumori ereditari e immunità nei contesti oncologici

Araldi, ‘con MedMal Report identifichiamo aree più a rischio’